Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 5/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | POLB | P06746 | 5/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10747423 | 0.96 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL13911196 | 0.85 | ALDH1A1 (0.50) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL23174566 | 0.81 | ALDH1A1 (0.50) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL6060993 | 0.80 | ALDH1A1 (0.49) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL13900459 | 0.79 | ALDH1A1 (0.49) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL7427500 | 0.78 | SYK (0.38) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL24535431 | 0.77 | MAPT (0.47) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL4546338 | 0.77 | RAPGEF4 (0.55) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL30558478 | 0.77 | RAPGEF4 (0.55) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL2484588 | 0.77 | ASIC3 (0.50) | ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111848494-B | Guanidine compounds and uses thereof | 伊谬诺米特医疗有限公司 | 2023-08-01 | — | — | CN | disclosed |
| EP-3131877-B1 | BIGUANIDE COMPOUNDS | IMMUNOMET THERAPEUTICS INC (US) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023275193-A1 | COMPOSITION COMPRISING AT LEAST ONE OXIDATION DYE, 1,3-PROPANEDIOL, AT LEAST ONE ALKALINE AGENT AND AT LEAST ONE FATTY SUBSTANCE | L'OREAL (FR) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023275197-A1 | COMPOSITION COMPRISING AT LEAST ONE OXIDATION DYE, AT LEAST ONE ALKALINE AGENT AND AT LEAST ONE LIQUID FATTY ALCOHOL AND AT LEAST ONE SOLID FATTY ALCOHOL | L'OREAL (FR) | 2023-01-05 | — | — | WO | disclosed |
| US-11465989-B2 | Guanidine compounds and use thereof | ImmunoMet Therapeutics, Inc. (US) | 2022-10-11 | — | — | US | disclosed |
| WO-2022129355-A1 | COSMETIC COMPOSITION COMPRISING A COMBINATION OF TWO PARTICULAR COUPLERS AND A NONIONIC SURFACTANT OF ALKYLPOLYGLYCOSIDE TYPE | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129352-A1 | COSMETIC COMPOSITION COMPRISING A COMBINATION OF TWO PARTICULAR COUPLERS AND N,N-DICARBOXYMETHYLGLUTAMIC ACID AND/OR ITS SALTS | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129389-A1 | COMPOSITION COMPRISING A PARTICULAR OXIDATION DYEING BASE, AT LEAST ONE PARTICULAR COUPLER AND AT LEAST ONE FATTY SUBSTANCE | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| EP-3904354-A1 | NEW IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | Perha Pharmaceuticals (FR) | 2021-11-03 | — | — | EP | disclosed |
| EP-3828174-A1 | PYRIDAZINONE DERIVATIVE | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2021-06-02 | — | — | EP | disclosed |
| US-20090048244-A1 | PYRROLOTRIAZINE COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2009-02-19 | — | — | US | disclosed |
| US-7297695-B2 | Pyrrolotriazine compounds as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-11-20 | — | — | US | disclosed |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | BONFANTI JEAN-FRANCOIS | 2007-04-26 | — | — | US | disclosed |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | BONFANTI JEAN-FRANCOIS | 2007-04-26 | — | — | US | disclosed |
| WO-2005058874-A1 | 5- OR 6-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2005-06-30 | — | — | WO | disclosed |
| EP-1148876-A4 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-1148876-A1 | CALCILYTIC COMPOUNDS | SmithKline Beecham Corporation (US) | 2001-10-31 | — | — | EP | disclosed |
| WO-2000045816-A1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (GB) | 2000-08-10 | — | — | WO | disclosed |
| US-4695571-A | Tricyclic oxindole antiinflammatory agents | PFIZER INC. (US) | 1987-09-22 | — | — | US | disclosed |
| WO-1986001510-A1 | TRICYCLIC OXINDOLE ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1986-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11465989-B2 | Guanidine compounds and use thereof | PC, TFAM, PCK2 | ALDH1A1 1471/4885MAPT 795/4885MEN1 4540/4885 |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SUB1, HYOU1 | ALDH1A1 3108/4885MAPT 4884/4885MEN1 2273/4885 |
| US-20090048244-A1 | PYRROLOTRIAZINE COMPOUNDS AS KINASE INHIBITORS | ERBB2, ERBB4, ERBB3 | ALDH1A1 3252/4885MAPT 2432/4885MEN1 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.